Clinical Trial Update: Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing cost-utility and physiological effects of low-dose naltrexone (LDN) in fibromyalgia patients; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Randomized Controlled Trial | Phase 4 | Status: ACTIVE_NOT_RECRUITING